Navigation Links
Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results
Date:8/6/2009

ice President of Global Safety, Regulatory Affairs and Quality for Chiron Biopharma, and in similar roles with Nektar Therapeutics, Elan Pharmaceuticals and Novartis Biopharma.
  • Jay Hagan as Senior Vice President of Corporate Development and Strategy. Jay has spent the bulk of his career at Amgen, including as head of Corporate Development and founder and Managing Director of Amgen Ventures.
  • Conference Call Today at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time)

    The Orexigen management team will host a teleconference and webcast to discuss the second quarter 2009 financial results and recent business highlights. The live call may be accessed by phone by calling (800) 510-9834 (domestic) or (617) 614-3669 (international), participant code 80431991. The webcast can be accessed live on the investor relations section of the Orexigen web site at http://www.orexigen.com, and will be archived for 14 days following the call. The archive may be accessed by calling (888) 286-8010 (domestic) or (617) 801-6888 (international), participant code 65772832.

    About Orexigen Therapeutics

    Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead investigational product, Contrave, has completed Phase 3 clinical trials and is on track for a regulatory submission with the FDA in the first half of 2010. The Company's second product, Empatic, is in the later stages of Phase 2 clinical development, with results expected in the second half of 2009. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss, through combination therapeutic approaches. Further information about the Company can
    '/>"/>

    SOURCE Orexigen Therapeutics, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine news :

    1. Orexigen(R) Therapeutics Prices Public Offering of Common Stock
    2. Orexigen(R) Therapeutics Announces Proposed Public Offering of Common Stock
    3. Orexigen(R) Therapeutics Announces In-Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave(R)
    4. Orexigen(R) Therapeutics Names Michael Narachi, 24-Year Biopharmaceutical Veteran, New President and Chief Executive Officer
    5. Orexigen(R) Therapeutics Names Patrick Mahaffy to Board of Directors
    6. Orexigen(R) Therapeutics to Speak at J.P. Morgan Healthcare Conference
    7. Orexigen(R) Therapeutics Announces Webcast of Third Quarter Financial Results on November 6, 2008
    8. Cell Therapeutics, Inc. (CTI) to Report Second Quarter Financial Results on August 6
    9. Quark Pharmaceuticals to Participate in IBCs Oligonucleotide Therapeutics: From Concept to Implementation Conference
    10. United Therapeutics Corporation Reports Second Quarter 2009 Financial Results
    11. Cell Therapeutics Initiates Process to Obtain Marketing Approval for Pixantrone in Europe
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/26/2015)... (PRWEB) May 26, 2015 The European imaging ... suggests over 45% of healthcare providers plan to make purchases. ... latest industry report. Data collected from these participants show that ... pathology takes a back seat. , “Many imaging IT ... year,” said peer60 CEO Jeremy Bikman. “This report details the ...
    (Date:5/26/2015)... (PRWEB) May 26, 2015 ... ceremonies during the Memorial Day weekend, celebrating the ... occurred on Pacifica’s picturesque Ladera Lane campus, located ... faculty, and alumni traveled to Santa Barbara from ... events. , The 2015 commencement ceremonies ...
    (Date:5/26/2015)... Beginning this fall, Boston University will ... Master of Social Work (MSW) program . Already available ... River Campus, the online option will be offered starting ... option is open to applicants holding an undergraduate social ... Education. Students entering the program will be granted 22 ...
    (Date:5/26/2015)... Pinehurst, NC (PRWEB) May 26, 2015 ... otolaryngologists at Pinehurst Surgical Center in Pinehurst, N.C. have ... area sinus surgery patients about chronic sinusitis and the ... questionnaire that can be used to determine if someone ... asks questions about symptoms and other factors that can ...
    (Date:5/25/2015)... 2015 Author Vincent N. Cefalu, Sr., MD. ... are overweight, and many of them aren’t aware of many ... that most people don’t realize the dangers of physical inactivity ... toxins that exist. There is also the fact ... serious tobacco is.” , In “ A Doctor’s Prescription for ...
    Breaking Medicine News(10 mins):Health News:peer60 report: European Healthcare IT Imaging Purchases: 2015 2Health News:Pacifica Graduate Institute Hosted its 2015 Commencement Ceremonies over Memorial Day Weekend 2Health News:Pacifica Graduate Institute Hosted its 2015 Commencement Ceremonies over Memorial Day Weekend 3Health News:Boston University to Offer Online Master of Social Work Advanced Standing Option 2Health News:Boston University to Offer Online Master of Social Work Advanced Standing Option 3Health News:Pinehurst Surgical Sinus Center Launches Pinehurst Balloon Sinuplasty Website 2Health News:New Book Reveals ‘A Doctor’s Prescription for Longevity and Survival’ 2Health News:New Book Reveals ‘A Doctor’s Prescription for Longevity and Survival’ 3
    ... on,Mental Illness (NAMI) is preparing to grade each of ... public to help by taking an online survey,-- and ... at http://www.nami.org/mentalhealthservices and,includes a version in Spanish., ... on America,s Mental,Healthcare System for Serious Mental Illnesses" ...
    ... Edward Duckworth is part of a new generation of ... on patients. , At Loyola University Hospital, Duckworth is ... aneurysms and to dramatically reduce seizures in epilepsy patients. ... or face, Duckworth is reaching the brain through much ...
    ... America,s Agenda to Launch Summit Conversations Series, ... All will be honoring Rep. Richard "Dick" Gephardt, ... commitment to affordable,health care for every American at ... the spirit of "health care for all Americans,",America,s ...
    ... beer, ... Stampede Light Plus(R), DALLAS, Aug. 20 ... Jessica Simpson,s daisy dukes body and healthy,lifestyle. The all-American beauty and ... choices. But she also makes,those smart choices with the beer she ...
    ... The National Institutes of,Health estimates that 45 million ... these headaches sufferers, the pain they experience is ... in your life, there,are many options to find ... Headaches result when muscles and blood vessels outside ...
    ... (DIA) will host Evidence-based Medicine and Health Technology ... Alexandria, VA). , ... ... 20, 2008 -- The http://www.diahome.org/DIAHome/ [Drug ...
    Cached Medicine News:Health News:Grading the States; Mental Health Services Survey 2Health News:Brain surgery is getting easier on patients 2Health News:Brain surgery is getting easier on patients 3Health News:America's Agenda to Honor Former House Majority Leader Richard Gephardt at Democratic National Convention 2Health News:Jessica Simpson Lends Healthy Image for Drink Smart Campaign 2Health News:Jessica Simpson Lends Healthy Image for Drink Smart Campaign 3Health News:Figure Skater Peggy Fleming Teams With HealthSaver: To Relieve Headaches, Be Proactive 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: To Relieve Headaches, Be Proactive 3Health News:Figure Skater Peggy Fleming Teams With HealthSaver: To Relieve Headaches, Be Proactive 4Health News:Figure Skater Peggy Fleming Teams With HealthSaver: To Relieve Headaches, Be Proactive 5Health News:DIA Conference to Provide New Paradigms in Evidence-Based Medicine and Health Technology Assessment 2
    (Date:5/22/2015)... -- The Mesothelioma Victims Center is incredibly passionate about ... best possible compensation, and they are also extremely focused ... caused by exposure to asbestos or their family ... options such as a recent possible medical breakthrough. For ... anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
    (Date:5/22/2015)... , May 22, 2015   InspireMD, Inc. ... stent embolic protection systems ("EPS"), today announced that its CGuard ... lead by principle investigator Prof. Piotr Musialek , at ... Paris, France . PARADIGM, an ... R cutaneous c A roti D revascularization I ...
    (Date:5/22/2015)...  In a sweeping analysis assessing the current state ... researchers conclude that there remains considerable room for ... age groups, but especially for adolescents and young adults. ... treatment, underscoring the need to address barriers to care ... type 1 patients achieve optimal metabolic control. ...
    Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5
    ... Data presented at,the annual meeting of the American ... the continuous use of intranasal corticosteroid,Nasacort AQ (triamcinolone ... age distribution among children aged 2-5 years old ... corticosteroids in the treatment of very,young children with ...
    ... Cancer Alliance,(LCA) called the new screening guidelines announced by ... the right direction,that will encourage those at high risk ... a CT scan.", LCA President Laurie Fenton Ambrose ... each year than all the other major cancers combined,until ...
    Cached Medicine Technology:New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ 2New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ 3New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ 4Lung Cancer Alliance Commends NCCN on Screening Guidelines 2
    ... The VersaPulse PowerSuite holmium laser combines ... for precise, virtually bloodless procedures. It ... urinary and gall bladder stones of ... multipurpose surgical tool. Because its laser ...
    ... quickly deliver up to 250 millijoules of ... single-pulse ablation. This type of high-energy pulse ... cleanest CO2 surgical laser available today. When ... independent adjustment of pulse energy and operating ...
    ... new CO2 laser system with intensities up ... an exclusive design for easy handling and ... is the leader in a new generation ... of Dekas laser devices, like safety and ...
    ... Laser hair removal for all ... Used for leg and ... Offers a large spot ... for fast treatment. An ...
    Medicine Products: